Compound Detail
CHEMBL155277
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1nc2cc3c4c(cccc4c2[nH]1)C(=O)N(CCN(C)CCCN(C)CCN1C(=O)c2cccc4c2c(cc2nc(C)[nH]c24)C1=O)C3=O
Basic Information
| ChEMBL ID | CHEMBL155277 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | AGVSNIPBBRXCTM-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
656.8
MW (Da)
4.51
ALogP
8
HBA
2
HBD
138.6
PSA (Ų)
0.21
QED
1
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.5
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-29 | IC50 | = | 320.0 | nM | 6.5 | In vitro concentration required to reduce cell number to 50% in human colon carc... | 12477366 |
| HeLa | IC50 | = | 800.0 | nM | 6.1 | In vitro concentration required to reduce cell number to 50% in human cervical c... | 12477366 |
| PC-3 | IC50 | = | 3220.0 | nM | 5.49 | In vitro concentration required to reduce cell number to 50% in human postrate c... | 12477366 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12477366 | 10.1021/jm020950q | HT-29 | 1 |
| 12477366 | 10.1021/jm020950q | HeLa | 1 |
| 12477366 | 10.1021/jm020950q | PC-3 | 1 |
Data from ChEMBL 36 via Core Engine